ACUTE LYMPHOCYTIC LEUKEMIA
Clinical trials for ACUTE LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at blood cancers in early trial
Disease control OngoingThis early-phase study tests a new treatment for people with B-cell lymphoma or leukemia that has returned or not responded to standard therapy. The treatment uses the patient's own T cells, which are modified in the lab to recognize and attack cancer cells carrying a protein cal…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 17, 2026 10:28 UTC
-
Frozen bone marrow transplants aim to help blood cancer patients
Disease control TerminatedThis study planned to test whether banked, frozen bone marrow from partially matched donors could be safely used for transplants in people with blood cancers like leukemia. Participants would have received a transplant followed by drugs to prevent graft-versus-host disease. The s…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated May 17, 2026 10:27 UTC
-
Cord blood boost: new stem cell therapy aims to speed recovery in blood cancer patients
Disease control OngoingThis study tests a new stem cell treatment called MGTA-456 for people with high-risk blood cancers like leukemia and lymphoma. The treatment uses a special process to grow more stem cells from donated umbilical cord blood before transplant. The goal is to help the body rebuild he…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo aims to supercharge immune cells against blood cancers
Disease control OngoingThis early-phase study tests whether adding the drug duvelisib after CAR T-cell therapy can help the immune cells stay active longer and reduce side effects like cytokine release syndrome. About 42 adults with non-Hodgkin lymphoma or acute lymphocytic leukemia will take part. The…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New safety check for Kids' leukemia drug BESPONSA
Disease control OngoingThis study looks at the safety of BESPONSA in children under 18 with a type of blood cancer called acute lymphocytic leukemia (ALL) that has come back or not responded to treatment. Researchers will track side effects and liver problems for up to a year. About 10 children who hav…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Sponsor: Pfizer • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New drug shows promise for leukemia patients with hidden cancer cells
Disease control OngoingThis study tests a drug called inotuzumab ozogamicin in adults with a type of leukemia (Ph-negative ALL) who still have tiny amounts of cancer cells left after initial chemotherapy. The goal is to see if the drug can wipe out those leftover cells. About 31 participants will recei…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 12, 2026 13:39 UTC